These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 22171131)

  • 1. Clinical presentation and management of Fasciola hepatica infection: single-center experience.
    Kaya M; Beştaş R; Cetin S
    World J Gastroenterol; 2011 Nov; 17(44):4899-904. PubMed ID: 22171131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic mass caused by Fasciola hepatica: a tricky differential diagnosis.
    Yilmaz B; Köklü S; Gedikoglu G
    Am J Trop Med Hyg; 2013 Dec; 89(6):1212-3. PubMed ID: 24080633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unusual radiological findings of Fasciola hepatica infection with huge cystic and multilocular lesions.
    Maeda T; Yamada H; Akao N; Iga M; Endo T; Koibuchi T; Nakamura T; Odawara T; Iwamoto A; Fujii T
    Intern Med; 2008; 47(5):449-52. PubMed ID: 18310981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical presentation of a very rare infection: parenchymal Fasciola hepatica.
    Sapmaz F; Kalkan IH; Guliter S; Nazlıoğlu A
    Turkiye Parazitol Derg; 2013; 37(4):305-6. PubMed ID: 24412878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fascioliasis: sonographic abnormalities of the biliary tract and evolution after treatment with triclabendazole.
    Richter J; Freise S; Mull R; Millán JC
    Trop Med Int Health; 1999 Nov; 4(11):774-81. PubMed ID: 10588772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Living Fasciola hepatica in biliary tree: a case report.
    Aminian K; Rezayat KA; Shafaghi A; Tanhaeevash R
    Ann Hepatol; 2012; 11(3):395-8. PubMed ID: 22481460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of patients diagnosed with fascioliasis: A six-year experience at a university hospital in Turkey.
    Boşnak VK; Karaoğlan İ; Sahin HH; Namiduru M; Pehlivan M; Okan V; Mete AÖ
    J Infect Dev Ctries; 2016 Apr; 10(4):389-94. PubMed ID: 27131001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and tolerability of triclabendazole in Cuban patients with latent and chronic Fasciola hepatica infection.
    Millán JC; Mull R; Freise S; Richter J;
    Am J Trop Med Hyg; 2000; 63(5-6):264-9. PubMed ID: 11421375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasciola hepatica-a "Diver" in the Biliary Tree.
    Martins A; Gonçalves Á; Almeida T; Lopes L; Midões A
    J Gastrointest Surg; 2017 Nov; 21(11):1959-1960. PubMed ID: 28634648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fasciola hepatica infection. Successful therapy using triclabendazole].
    Markwalder K; Koller M; Goebel N; Wolff K
    Schweiz Med Wochenschr; 1988 Jul; 118(27-28):1048-52. PubMed ID: 3413464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An incidental case of biliary fascioliasis mimicking cholangiocellular carcinoma.
    Şenateş E; Doğan A; Şenates BE; Bodakçi E; Bekçibasi M
    Infez Med; 2014 Dec; 22(4):313-6. PubMed ID: 25551848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history, clinicoradiologic correlates, and response to triclabendazole in acute massive fascioliasis.
    Marcos LA; Tagle M; Terashima A; Bussalleu A; Ramirez C; Carrasco C; Valdez L; Huerta-Mercado J; Freedman DO; Vinetz JM; Gotuzzo E
    Am J Trop Med Hyg; 2008 Feb; 78(2):222-7. PubMed ID: 18256419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasciola hepatica infection: clinical and computerized tomographic findings of ten patients.
    Aksoy DY; Kerimoğlu U; Oto A; Ergüven S; Arslan S; Unal S; Batman F; Bayraktar Y
    Turk J Gastroenterol; 2006 Mar; 17(1):40-5. PubMed ID: 16830276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection with Fasciola hepatica.
    Aksoy DY; Kerimoglu U; Oto A; Erguven S; Arslan S; Unal S; Batman F; Bayraktar Y
    Clin Microbiol Infect; 2005 Nov; 11(11):859-61. PubMed ID: 16216098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic imaging in the study of human hepatobiliary fascioliasis.
    Cantisani V; Cantisani C; Mortelé K; Pagliara E; D'Onofrio M; Fernandez M; D'Ambrosio U; Lombardi V; Marigliano C; Ricci P
    Radiol Med; 2010 Feb; 115(1):83-92. PubMed ID: 20012922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apparent triclabendazole-resistant human Fasciola hepatica infection, the Netherlands.
    Winkelhagen AJ; Mank T; de Vries PJ; Soetekouw R
    Emerg Infect Dis; 2012 Jun; 18(6):1028-9. PubMed ID: 22607719
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatobiliary fascioliasis: imaging characteristics with a new finding.
    Koç Z; Ulusan S; Tokmak N
    Diagn Interv Radiol; 2009 Dec; 15(4):247-51. PubMed ID: 19908182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of triclabendazole (Fasinex) against immature and adult Fasciola hepatica in experimentally infected cattle.
    Shi FH; Lin BF; Qian CG; Li M; Fang MB; Ma JL; Shen W; Wang SW; Jian XL
    Vet Parasitol; 1989 Sep; 33(2):117-24. PubMed ID: 2800300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservative management of biliary obstruction due to Fasciola hepatica.
    Mannstadt M; Sing A; Leitritz L; Brenner-Maucher K; Bogner J
    Clin Infect Dis; 2000 Nov; 31(5):1301-3. PubMed ID: 11073771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biliary obstruction caused by the liver fluke, Fasciola hepatica.
    Ishikawa T; Meier-Stephenson V; Heitman SJ
    CMAJ; 2016 Apr; 188(7):524-526. PubMed ID: 26728843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.